GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NextCell Pharma AB (OSTO:NXTCL) » Definitions » Shares Buyback Ratio %

NextCell Pharma AB (OSTO:NXTCL) Shares Buyback Ratio % : 0.00 (As of Jun. 20, 2024)


View and export this data going back to 2017. Start your Free Trial

What is NextCell Pharma AB Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. NextCell Pharma AB's current shares buyback ratio was 0.00%.


NextCell Pharma AB Shares Buyback Ratio % Historical Data

The historical data trend for NextCell Pharma AB's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NextCell Pharma AB Shares Buyback Ratio % Chart

NextCell Pharma AB Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Shares Buyback Ratio %
Get a 7-Day Free Trial Premium Member Only -122.66 -15.17 -31.73 - -

NextCell Pharma AB Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

NextCell Pharma AB Shares Buyback Ratio % Calculation

NextCell Pharma AB's Shares Buyback Ratio for the fiscal year that ended in Aug. 2023 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Aug. 2022 ) - Shares Outstanding (EOP) (A: Aug. 2023 )) / Shares Outstanding (EOP) (A: Aug. 2022 )
=(43.5248 - 43.5248) / 43.5248
=0.00%

NextCell Pharma AB's Shares Buyback Ratio for the quarter that ended in Feb. 2024 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Nov. 2023 ) - Shares Outstanding (EOP) (A: Feb. 2024 )) / Shares Outstanding (EOP) (A: Nov. 2023 )
=(43.5248 - 43.5248) / 43.5248
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NextCell Pharma AB Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of NextCell Pharma AB's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


NextCell Pharma AB (OSTO:NXTCL) Business Description

Traded in Other Exchanges
Address
Karolinska Institutet Science Park, Halsovagen 7, Huddinge, SWE, 14157
NextCell Pharma AB is a healthcare services provider. The company is engaged in the research of stem cell and is developing the candidate drug ProTrans for the treatment of diabetes and immunosuppression in kidney transplants.

NextCell Pharma AB (OSTO:NXTCL) Headlines

No Headlines